Why SPARKing?
Dr. Daria Mochly-Rosen is a Professor of Chemical and Systems Biology at Stanford University where she leads multi-disciplinary research on the molecular mechanisms of diseases.
She has published more than 290 papers and holds over 50 patents. She has founded three biotech companies, including KAI Pharmaceuticals (acquired by Amgen in 2012) and initiated several clinical trials.
Her experience in translating basic research into successful drug development projects led her to found SPARK, Stanford’s translational research program, in 2006.
The SPARK model has now been adopted in currently more than 70 institutes on all continents and she serves as President and Founder of the SPARK GLOBAL organization.
In this webinar she will share with us her story on translating her research discoveries into therapeutics, giving insights into:
- the countless lessons she has learned from her own translational effort,
- how her experience led to the establishment of the SPARK program,
- how SPARK has helped other projects to advance research discoveries from bench to bedside world-wide.
If you face problems with the registration link, please use the direct link (Meeting Registration - Zoom). Note that the number of participants is limited, therefore register asap!
The webinar is open to all interested staff and students from SPARK associated organizations. It is organized by SPARK Finland.
----------------------
SPARK EUROPE WEBINAR SERIES SPRING 2021
The webinar series will be organized by the different SPARK sites from all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK FLI in Jena, SPARK Poland and SPARK Tel Aviv. The series takes advantage of the collective expertise and experiences from top-quality speakers and will cover topics from design thinking to challenges in selling complex high-tech products. The online webinar series takes place twice per month on Wednesday at 16:00 - 17:00 CET.
